UTSZJRADRCSINL-UHFFFAOYSA-N
C38H42F8N12 — CID 123836936
Data last refreshed: (MolForge compound catalog, from PubChem)
About UTSZJRADRCSINL-UHFFFAOYSA-N
UTSZJRADRCSINL-UHFFFAOYSA-N (PubChem CID 123836936) has the molecular formula C38H42F8N12 and a molecular weight of 818.82 g/mol. Its IUPAC name is 2-[3,3-difluoro-5-[3-[2-piperidin-1-yl-6-[[4-(trifluoromethyl)-2-pyridinyl]amino]pyrimidin-4-yl]pyrrolidin-1-yl]piperidin-1-yl]-6-pyrrolidin-3-yl-N-[4-(trifluoromethyl)-2-pyridinyl]pyrimidin-4-amine.
Molecular Properties
| Compound Name | UTSZJRADRCSINL-UHFFFAOYSA-N |
|---|---|
| PubChem CID | 123836936 |
| Molecular Formula | C38H42F8N12 |
| Molecular Weight | 818.82 g/mol |
| Exact Mass | 818.35 |
| IUPAC Name | 2-[3,3-difluoro-5-[3-[2-piperidin-1-yl-6-[[4-(trifluoromethyl)-2-pyridinyl]amino]pyrimidin-4-yl]pyrrolidin-1-yl]piperidin-1-yl]-6-pyrrolidin-3-yl-N-[4-(trifluoromethyl)-2-pyridinyl]pyrimidin-4-amine |
| SMILES | FC1(F)CC(N2CCC(c3cc(Nc4cc(C(F)(F)F)ccn4)nc(N4CCCCC4)n3)C2)CN(c2nc(Nc3cc(C(F)(F)F)ccn3)cc(C3CCNC3)n2)C1 |
| InChI | InChI=1S/C38H42F8N12/c39-36(40)18-27(21-58(22-36)35-50-28(23-4-8-47-19-23)16-32(55-35)52-30-14-25(5-9-48-30)37(41,42)43)57-13-7-24(20-57)29-17-33(54-34(51-29)56-11-2-1-3-12-56)53-31-15-26(6-10-49-31)38(44,45)46/h5-6,9-10,14-17,23-24,27,47H,1-4,7-8,11-13,18-22H2,(H,48,50,52,55)(H,49,51,53,54) |
| InChIKey | UTSZJRADRCSINL-UHFFFAOYSA-N |
| XLogP | 7.35 |
| TPSA | 123.15 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 12 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 58 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 818.82 |
| LogP ≤ 5 | 7.35 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 12 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 123836936 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.